Adam Testro

Director of Liver and Intestinal Transplant Medicine @Austin_Health | Professor of Gastroenterology @UniMelb | Terlipressin enthusiast.

[Liver Transplantation Journal (LTxJournal) @LTxJournal]

Tricuspid regurgitation predicts mortality after liver transplantation in patients with high MELD score: A retrospective cohort study

https://t.co/CMQmSIqooA

[Adam Testro @GutFailure]

@pgholam 💯

[Austin Hepatology Research Group @austin_HRG]

What about HLA compatibility and liver transplant outcomes? 👇

@dotliu_ @AvikMajumd @mariej_sinclair @GutFailure

https://t.co/QfTDe8az6Z

[Austin Hepatology Research Group @austin_HRG]

What about predictive scores for post-TIPs outcomes? Here’s our data from an Australian population.

https://t.co/Pr0l8NEpYe

[Austin Hepatology Research Group @austin_HRG]

In this paper, Angus Jeffrey et al describe the trajectory of further decompensation following first decompensation in an Australian setting.
>50% die or require liver transplantation within 5 years!

https://t.co/UPgkPvKBRF

[Austin Hepatology Research Group @austin_HRG]

The updated GESA Portal Hypertension Management Guidelines.

Lead author @AvikMajumd along with 6 other @Austin_Health authors and colleagues from around Australia.

https://t.co/za9Q3HSp3i

[Austin Hepatology Research Group @austin_HRG]

Here’s our latest offering on the current status of Intestinal Transplantation in Australia.

https://t.co/fToBnUkT8L

[Hepatology International @hepinternation1]

Explore the Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension, presented as a comprehensive consensus statement.

This article provides evidence-based guidance on patient selection, procedural considerations, and post-TIPS management, supporting optimized clinical decision-making and improved patient outcomes.

👉Read the full article: https://t.co/wAXX2Mpo2p

#Hepatology #PortalHypertension #TIPS #ClinicalGuidelines #LiverDisease #HepatologyInternational #MedicalResearch #HealthcareProfessionals

[Adam Testro @GutFailure]

@DfarmerDouglas @CarolynSmullin @UCLAHealth @UCLASurgery @UCLASurgeryRes Amazing. Well done.

[Austin Hepatology Research Group @austin_HRG]

Pleased to share the 2025 @Austin_Health Liver and Intestinal Transplant Medicine Research Report.

It was another very productive year for our small team of busy clinicians.

[Adam Testro @GutFailure]

🚨Low ticket alert 🚨

We are only 4 weeks out from the @Austin_Health ACTER Advanced Liver Disease Symposium - Critical Care Hepatology.

A must for clinicians in the gastroenterology and critical care/ICU space.

Avoid disappointment and book now 👇
https://t.co/aMyYdZILYp

[Austin Hepatology Research Group @austin_HRG]

Meet the speakers #4:

Dr Caleb Fisher
BA, BSc, MBBS, FCICM, FRACP
Department of Intensive Care, Austin Health.
Department of Critical Care, The University of Melbourne.

[Adam Testro @GutFailure]

An excellent review from our @Austin_Health team 👇

[Austin Hepatology Research Group @austin_HRG]

Everything you need to know about “Cardiohepatology” 👇

CardioHepatology: Exploring the Interplay Between Cirrhosis, Cirrhotic Cardiomyopathy, Coronary Artery Disease, and Liver Transplantation - Heart, Lung and Circulation https://t.co/nOU3dBrNKb

[Austin Hepatology Research Group @austin_HRG]

Meet the speakers #3:

Dr Anoop Koshy is an Interventional Cardiologist based at Austin Health.

[Austin Hepatology Research Group @austin_HRG]

Meet the speakers #2:

Professor James O’Beirne MBBS (Hons) MD FRACP FRCP EDIC

Prof. O’Beirne is a Consultant Hepatologist at the Sunshine Coast University Hospital, Queensland.

[Adam Testro @GutFailure]

https://t.co/aMyYdZILYp

[Adam Testro @GutFailure]

Meet our 2026 International Keynote speaker.

William Bernal is Professor of Liver Critical Care Medicine at Kings College Hospital, London, serving one of the largest liver transplant programs in Europe.

[Adam Testro @GutFailure]

Professor Bernal will join us in Melbourne in February to present on “Acute Liver Failure” and “Acute on Chronic Liver Failure”.

Register now before it’s too late.

https://t.co/T5YoSZp4va

[Frontline Gastro @FrontGastro_BMJ]

👏 Amazing new publication from @mariej_sinclair et al @Austin_Health @UniMelb 🥳 . The authors prospectively assessed the impact of 12 weeks of home continuous terlipressin infusion in decompensated cirrhosis 🏠 💉🧑‍⚕️ .

Novel findings of ⬇️ renin, ⬇️ aldosterone and ⬆️ ACE2

🤔 Should we be using terli for longer? Should we be using it to prevent HRS? 💭

https://t.co/ZTIY1aS6Cf

@PhilSmithIsBack @OTavabie @dr_aditi_kumar @TrevorTabone @eathar_s @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman @BASLedu @BSGtrainees @WorldGastroOrg @ulstergastro @pancreatitis_nl @SEEDendoscopia @EASLedu @AmCollegeGastro @Aegastro @SAGES_updates @UHSEndoscopy @WAGE_media

#BSGLIVE25 #GITwitter #livertwitter #gastroenterology #MedEd #Renal